Clearside Biomedical Inc
NASDAQ:CLSD
During the last 3 months Clearside Biomedical Inc insiders bought 13.8k USD , and have not sold any shares. The stock price has dropped by 9% over this period (open performance analysis).
The last transaction was made on
Feb 24, 2025
by
Thorp Clay
(Chief Legal Officer and General Counsel)
, who
bought
13.8k USD
worth of CLSD shares.
During the last 3 months Clearside Biomedical Inc insiders bought 13.8k USD , and have not sold any shares. The stock price has dropped by 9% over this period (open performance analysis).
The last transaction was made on
Feb 24, 2025
by
Thorp Clay
(Chief Legal Officer and General Counsel)
, who
bought
13.8k USD
worth of CLSD shares.
Clearside Biomedical Inc
Glance View
Clearside Biomedical, Inc. is a biopharmaceutical company, which engages in the development of drug therapies to treat blinding diseases of the eye. The company is headquartered in Alpharetta, Georgia and currently employs 34 full-time employees. The company went IPO on 2016-06-02. The firm is focused on developing and delivering therapies to the back of the eye diseases through the suprachoroidal space (SCS). Its SCS injection platform utilizing its SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted delivery of a variety of therapies to the macula, retina or choroid to preserve and improve vision in patients with sight-threatening eye diseases. The company is focused on developing its own pipeline of small molecule product candidates for administration via its SCS Microinjector, and it also partners with companies developing other ophthalmic therapeutics to be administered using its SCS injection platform. Its lead product candidate, XIPERE, is a preservative-free suspension of the corticosteroid triamcinolone acetonide (TA), formulated for administration through suprachoroidal injection. Its pipeline includes CLS-AX, CLS-301 and Gene Therapy.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
You don't have any saved screeners yet